http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2455009-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f83739934fdc2a7659b796aa25a36413 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08 |
| filingDate | 2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06a335bab2e00160a3beeab99a5a64ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b988ec2379244b609d67a3e2335a84d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d525bc18d20d28e28c9080002730cebb |
| publicationDate | 2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2455009-C1 |
| titleOfInvention | Method of treating acne |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, specifically dermatology, and may be used for treating the acne. A standard drug-induced therapy is prescribed. From the first day of treatment, it is added with 10 sessions of subcutaneous puncture of morphological acne elements with an ozone-oxygen mixture with the ozone concentration of 3500 mcg/ml. The sessions are performed every second day. The volume of the injected ozone-oxygen mixture per each puncture makes 0.2 ml to 0,6 ml. Besides, the preparation Imunorix 800 mg is prescribed in the morning and in the evening orally between meals for the first 14 days of the therapy. Then, for the following 14 days, Imunorix is dosed 400 mg according to the previous regimen. n EFFECT: method allows 29% higher clinical effectiveness in severe and moderate acne, including in patients with accompanying cardiovascular pathologies and with aggravated inflammatory diseases, due to lower intensity of inflammation processes and normalised immune status. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2557991-C1 |
| priorityDate | 2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.